The Na+/K+ ATPase Inhibitor Ouabain Attenuates Stemness and Chemoresistance of Osteosarcoma Cells.

CONCLUSIONS This work provides a potential compound for treating OS patients, especially OS patients with chemoresistance. PMID: 31822650 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31822650?dopt=Abstract

Source: Medical Science Monitor - December 12, 2019 Category: Research Tags: Med Sci Monit Source Type: research